This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Sridhar Reddy Male: Innovator in Pharmaceutical Chemistry
Introduction
Sridhar Reddy Male is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of polymorphic forms of Belinostat. With a total of 2 patents to his name, his work is recognized for its potential impact on patient treatment.
Latest Patents
Sridhar's latest patents focus on the polymorphic forms of Belinostat and the processes for their preparation. The inventions relate to the pharmaceutical composition of these polymorphic forms and their use in treating patients in need. This innovative approach aims to enhance the efficacy and safety of Belinostat, a drug used in cancer treatment.
Career Highlights
Sridhar Reddy Male is currently associated with Fresenius Kabi Oncology Limited, where he applies his expertise in pharmaceutical development. His work at the company underscores his commitment to advancing cancer therapies and improving patient outcomes.
Collaborations
Sridhar collaborates with talented professionals in his field, including coworkers Saurabh Upadhyay and Suneel Kumar Sharma. These collaborations foster a dynamic environment for innovation and research.
Conclusion
Sridhar Reddy Male's contributions to pharmaceutical chemistry, particularly through his patents on Belinostat, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile